Contrast Agent Gadobutrol Approved for Use in Cardiac MRI
The FDA has approved Gadavist injection for use in cardiac MRI to assess myocardial perfusion and late gadolinium enhancement in adult patients with known or suspected CAD.
Cardiovascular Disease
Guidance Issued for Management of Fontan Circulation
A scientific statement with recommendations for follow-up care in patients with Fontan circulation surviving into adulthood was published.
Markers of IL-1 Activation Predict First-Time MI in Patients With HIV
People with HIV and cardiovascular disease have higher levels of the interleukin-1 receptor antagonist and soluble regulator sIL-1R1 up to 10 years before the first myocardial infarction.
Performance of CVD Risk Prediction Algorithms in People Living With HIV
Algorithms may help predict cardiovascular disease risk in people living with HIV.
AHA Guidelines for Prevention and Management of Cardiovascular Disease in HIV
A scientific statement from the American Heart Association was published in Circulation, with the purpose of providing a thorough review of available evidence on HIV-associated cardiovascular disease.
Case Study: Reducing Future ASCVD Risk Post-STEMI
Angio – CT scan of the postoperative condition of a 57 yearold male patient who has been treated for stenosis of the left anterior interventricular artery by an implantation of two contiguous stents (blue), axial section. (c) Sovereign A 50-year-old man comes to your office after being admitted to the hospital with a ST-elevated myocardial…
Inclisiran Associated With Sustained LDL-C Reduction in ORION-3 Study
The investigational treatment inclisiran (The Medicines Company) was associated with a sustained reduction in low density lipoprotein cholesterol (LDL-C) in patients with atherosclerotic cardiovascular disease (ASCVD) or ASCVD-risk equivalents and elevated LDL-C despite maximum tolerated doses of LDL-C lowering therapies.
Serum Free Fatty Acid Level Verifies Fasting State in Children
Serum free fatty acid concentrations can distinguish children’s fed and fasting states.
Duration of Antibiotic Use and CVD Risk in Women: What’s the Link?
According to the results of a recent study, the duration of antibiotic exposure in women during middle and older adulthood may significantly impact the risk of future cardiovascular (CVD) events. The study aimed to determine the association between both the duration of antibiotic exposure as well as the period of antibiotic use and subsequent…
Evidence Supporting Niacin Use for CV Disease Prevention Evaluated
Evidence supporting the clinical benefit of niacin monotherapy for secondary prevention of CVD appears to be outdated.
Next post in Dyslipidemia
